| [Table_Finance] 财务摘要(百万元) | 2024A | 2025A | 2026E | 2027E | 2028E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 1,555 | 1,748 | 2,076 | 2,411 | 2,739 | | (+/-)% | -11.0% | 12.4% | 18.8% | 16.1% | 13.6% | | 净利润(归母) | 121 | 190 | 223 | 273 | 318 | | (+/-)% | -17.0% | 56.6% | 17.4% | 22.7% | 16.2% | | 每股净收益(元) | 0.63 | 0.99 | 1.16 | 1.43 | 1.66 | | 净资产收益率(%) | 6.5% | 9.5% | 10.4% | 12.0% | 13.1% | | 市盈率(现价&最新股本摊薄) | 27.00 | 17.25 | 14.69 | 11.98 | 10.30 | 索宝蛋白（603231）年报&一季报点评 | [姓名table_Authors] | 电话 | 邮 ...